Evidence-Based Complementary and Alternative Medicine

Natural Products as a Source for New Leads in Cancer Research and Treatment


Publishing date
16 Mar 2018
Status
Published
Submission deadline
27 Oct 2017

Lead Editor

1University of Coimbra, Coimbra, Portugal

2Johannes Gutenberg University, Mainz, Germany

3University of Hull, Hull, UK

4Universidade Tiradentes, Aracaju, Brazil

5Instituto Politécnico de Leiria, Peniche, Portugal


Natural Products as a Source for New Leads in Cancer Research and Treatment

Description

Despite recent advances in treatment modalities, cancer remains a major source of morbidity and mortality throughout the world. In the United States, cancer is the leading cause of death for individuals less than 85 years of age. Moreover, the incidence of many cancers, including cancers of the skin, prostate, breast, and kidney, continues to increase. A study, led by Cancer Research UK (CRUK), indicated that one in two individuals born after 1960 will be diagnosed with cancer at some point in their lifetime.

Cancer is a general term that refers to over 100 distinct pathologies affecting many different tissues and cell types. However, all forms of cancer are characterised by abnormal cell growth resulting from inherited or environmentally induced genomic instability and mutations. Cancer is a disorder that involves cellular transformation, dysregulation of apoptosis and other types of cell death, increased proliferation, angiogenesis, immune evasion, inflammatory responses, and, ultimately, metastatic spread.

Inflammation is a key hallmark of cancer and has a key role in promoting tumourigenesis. Chronic inflammation is often associated with tumourigenic processes, such as prolonged physical irritation and bacterial or viral infection, as well as other inflammatory processes. Moreover, cancer cells that are quiescent or slowly proliferating are refractory to the cytotoxic effect of conventional chemotherapy. Cancer cells also frequently become resistant to chemotherapy because of various cellular changes, as well as physical and chemical characteristics of the tumour microenvironment, such as hypoxia and acidosis. Therefore, the development of a new class of anticancer drugs that lack the toxicity of conventional chemotherapeutic agents and are unaffected by common mechanisms of chemoresistance would be a major advance in cancer therapeutics.

Statistics reveal natural sources as the most promising pool for drug candidates or drug leads. The continuing search for bioactive molecules from natural sources leads to various published papers validating the use of extracts in a wide range of activities. There are several important chemotherapy agents already in use that are developed from plants, such as taxanes, certain topoisomerase inhibitor, and vinca alkaloids. Therefore, biologically active compounds obtained from natural products continue to offer opportunities as sources of new anticancer therapeutic leads.

We invite authors to contribute original research articles as well as review articles that will illustrate and stimulate the continuing effort in drug discovery and drug development using natural products as source of bioactive molecules in cancer research and treatment.

Potential topics include but are not limited to the following:

  • Natural product cancer chemopreventive agents
  • Combination strategies between natural products and conventional therapeutic approaches as anticancer agents
  • Impact of use of natural compounds on metastasis biology
  • Impact of natural products on the tumour microenvironment: inflammation and immunity
  • Cancer drug discovery and anticancer drug development
  • Review of preclinical and clinical studies of use of volatile oils as anticancer agents
  • Encapsulation of natural products in nanoparticles for antitumoral activity
  • Use of monoterpenes for cytotoxicity activity

Articles

  • Special Issue
  • - Volume 2018
  • - Article ID 8243680
  • - Editorial

Natural Products as a Source for New Leads in Cancer Research and Treatment

Célia Cabral | Thomas Efferth | ... | Marco F. L. Lemos
  • Special Issue
  • - Volume 2018
  • - Article ID 7271509
  • - Review Article

Potential of Mushroom Compounds as Immunomodulators in Cancer Immunotherapy: A Review

Peter Amwoga Ayeka
  • Special Issue
  • - Volume 2018
  • - Article ID 3149362
  • - Review Article

Anticancer Properties of Essential Oils and Other Natural Products

K. Blowman | M. Magalhães | ... | I. M. Pires
  • Special Issue
  • - Volume 2018
  • - Article ID 6328970
  • - Review Article

Flavonoids Effects on Hepatocellular Carcinoma in Murine Models: A Systematic Review

Estefanny Ruiz García | Eliana Alviárez Gutierrez | ... | Reggiani Vilela Gonçalves
  • Special Issue
  • - Volume 2018
  • - Article ID 7202548
  • - Research Article

Propolin C Inhibited Migration and Invasion via Suppression of EGFR-Mediated Epithelial-to-Mesenchymal Transition in Human Lung Cancer Cells

Jih-Tung Pai | Yi-Chin Lee | ... | Meng-Shih Weng
  • Special Issue
  • - Volume 2018
  • - Article ID 5291517
  • - Research Article

Traditional Herbal Formula NPC01 Exerts Antiangiogenic Effects through Inhibiting the PI3K/Akt/mTOR Signaling Pathway in Nasopharyngeal Carcinoma Cells

Li Yanwei | Yang Yinli | Zhanyu Pan
  • Special Issue
  • - Volume 2018
  • - Article ID 2517080
  • - Research Article

Autumn Royal and Ribier Grape Juice Extracts Reduced Viability and Metastatic Potential of Colon Cancer Cells

Manuel Valenzuela | Lorena Bastias | ... | Joan Villena
  • Special Issue
  • - Volume 2017
  • - Article ID 5310563
  • - Research Article

Inhibition of Tumor Growth of Human Hepatocellular Carcinoma HepG2 Cells in a Nude Mouse Xenograft Model by the Total Flavonoids from Arachniodes exilis

Huimin Li | Dengzhao Jiang | ... | Jiazhong Wu
  • Special Issue
  • - Volume 2017
  • - Article ID 6750274
  • - Research Article

MMP-Inhibitory Effects of Flavonoid Glycosides from Edible Medicinal Halophyte Limonium tetragonum

Min Joo Bae | Fatih Karadeniz | ... | Chang-Suk Kong
  • Special Issue
  • - Volume 2017
  • - Article ID 5787218
  • - Research Article

Curcumin Induces Autophagy, Apoptosis, and Cell Cycle Arrest in Human Pancreatic Cancer Cells

Yaping Zhu | Shurui Bu
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate27%
Submission to final decision68 days
Acceptance to publication33 days
CiteScore2.900
Impact Factor1.813
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.